SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-090912
Filing Date
2024-04-09
Accepted
2024-04-09 16:47:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-09

Document Format Files

Seq Description Document Type Size
1 ARS d493884dars.pdf ARS 2058568
  Complete submission text file 0001193125-24-090912.txt   2836660
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37923 | Film No.: 24833273
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)